Skip to main content
. 2023 Dec 20;110(4 Suppl):38–43. doi: 10.4269/ajtmh.22-0727

Figure 3.

Figure 3.

Forest plot of comparison: mass relapse prevention (MRP) versus no MRP on prevalence of Plasmodium vivax infection.